|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 27/00 | |
| A61K 38/13 | |||
| A61F 2/16 |
| (11) | Number of the document | 2152291 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08747428.4 |
| Date of filing the European patent application | 2008-05-02 | |
| (97) | Date of publication of the European application | 2010-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/062325 |
| Date | 2008-05-02 |
| (87) | Number | WO 2008/137617 |
| Date | 2008-11-13 |
| (30) | Number | Date | Country code |
| 915950 P | 2007-05-04 | US |
| (72) |
DONNENFELD, Eric, D., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | USE OF CYCLOSPORINES IN THE TREATMENT OF PATIENTS WITH INTRAOCULAR LENSES |
| USE OF CYCLOSPORINES IN THE TREATMENT OF PATIENTS WITH INTRAOCULAR LENSES |